Baird Reiterates Outperform on Voyager Therapeutics (VYGR) Following Announced AbbVie Collaboration
Tweet Send to a Friend
Baird analyst, Brian Skorney, reiterated an Outperform rating and $27.00 price target on Voyager Therapeutics (NASDAQ: VYGR) vollowing the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
